Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Paul Edison, Benjamin R. Underwood et al.|Trials|2019Cited by 214
Evaluation of liraglutide in the treatment of Alzheimer's diseasePaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Alzheimer s & Dementia|2021Cited by 72
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?Grazia Daniela Femminella, Paul Edison, Nicholas R Livingston et al.|Alzheimer s Research & Therapy|2021Cited by 59
Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trialPaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Nature Medicine|2025Cited by 41
MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASEPaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Alzheimer s & Dementia|2023Cited by 18